Title : Efficacy and safety of imatinib mesylate (Glivec) in combination with interferon-alpha (IFN-alpha) in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).

Pub. Date : 2003 Oct

PMID : 14513038






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Experimental data suggest that interferon-alpha (IFN-alpha) enhances the antileukemic activity of imatinib. Imatinib Mesylate interferon alpha 1 Homo sapiens